|
|
|
Volumn 61, Issue 1, 2015, Pages 39-49
|
|
Management of hepatitis C infection among patients with renal failure
a a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-(2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXAN-2-CARBOXAMIDE;
PROLINE;
ANALOGS AND DERIVATIVES;
CHRONIC KIDNEY FAILURE;
COMPLICATION;
HEALTH;
HEPATITIS C;
HUMAN;
INCIDENCE;
ITALY;
KIDNEY TRANSPLANTATION;
PRACTICE GUIDELINE;
PREVALENCE;
TREATMENT OUTCOME;
ANTIVIRAL AGENTS;
GLOBAL HEALTH;
GUIDELINES AS TOPIC;
HEPATITIS C;
HUMANS;
INCIDENCE;
ITALY;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
PREVALENCE;
PROLINE;
TREATMENT OUTCOME;
|
|
EID: 84928813514
PISSN: 1121421X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (0)
|